MEDICAL PROPERTIES TRUST INC (MPT) Forecast, Price Target & Analyst Ratings
NYSE:MPT • US58463J3041
5.47 USD
-0.03 (-0.55%)
At close: Mar 6, 2026
5.4695 USD
0 (-0.01%)
After Hours: 3/6/2026, 8:04:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDICAL PROPERTIES TRUST INC (MPT).
Forecast Snapshot
Consensus Price Target
$5.83
+ 6.56% Upside
Next Earnings Forecast
Release DateApr 29, 2026
PeriodQ1 / 2026
EPS Estimate$0.00
Revenue Estimate245.52M
ChartMill Buy Consensus
53.75%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$5.83
Upside
+ 6.56%
From current price of $5.47 to mean target of $5.83, Based on 16 analyst forecasts
Low
$4.55
Median
$5.10
High
$8.40
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
16 analysts have analysed MPT and the average price target is 5.83 USD. This implies a price increase of 6.56% is expected in the next year compared to the current price of 5.47.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
53.75%
MPT was analyzed by 16 analysts. The buy percentage consensus is at 54. So analysts seem to be rather neutral about MPT.
In the previous month the buy percentage consensus was at a similar level.
MPT was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-02 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 29, 2026
PeriodQ1 / 2026
EPS Estimate$0.00
Revenue Estimate245.52M
Revenue Q2Q9.71%
EPS Q2Q101.68%
Number of Analysts4
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
MPT is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is 0 USD and the consensus revenue estimate is 245.52M USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 871.799M -43.50% | 995.547M 14.19% | 972.022M -2.36% | 1.009B 3.80% | 1.081B 7.14% | 1.055B -2.41% | 1.088B 3.13% | 1.121B 3.03% | |
| EBITDA YoY % growth | 697.411M -48.31% | 840.595M 20.53% | 812.592M -3.33% | 853.93M 5.09% | 919.35M 7.66% | 871.63M -5.19% | 898.9M 3.13% | 926.17M 3.03% | |
| EBIT YoY % growth | 81.284M -91.90% | 386.846M 375.92% | 539.775M 39.53% | 543.76M 0.74% | 571.54M 5.11% | N/A | N/A | N/A | |
| Operating Margin | 9.32% | 38.86% | 55.53% | 53.89% | 52.87% | N/A | N/A | N/A | |
| EPS YoY % growth | 0.35 -76.67% | -2.64 -854.29% | -0.28 89.39% | 0.09 133.19% | 0.16 71.20% | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.00 101.68% | 0.02 -15.82% | 0.03 123.31% | 0.04 23.46% | 0.06 1,701.80% | 0.06 259.93% | 0.06 100.00% | 0.05 36.35% |
| Revenue Q2Q % growth | 245.52M 9.71% | 249.52M 3.81% | 252.26M 6.20% | 266.63M -1.37% | 273.18M 11.27% | 274.72M 10.10% | 272.98M 8.21% | 273.43M 2.55% |
| EBITDA Q2Q % growth | 201.84M 14.87% | 207.54M -23.20% | 209.87M -35.81% | 233.25M -47.22% | 234.17M 16.02% | 237.87M 14.61% | 236.84M 12.85% | 238.74M 2.35% |
| EBIT Q2Q % growth | 105.82M -4.05% | 113.07M -17.21% | 113.84M -8.05% | 182.2M 7.74% | 187.05M 76.76% | 187.15M 65.52% | 187.66M 64.85% | 187.46M 2.89% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
3.88%
Revenue Next 5 Year
3.56%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
20.45%
EBIT Next 5 Year
13.18%
MEDICAL PROPERTIES TRUST INC / MPT Forecast FAQ
What is the average price target for MEDICAL PROPERTIES TRUST INC (MPT) stock?
16 analysts have analysed MPT and the average price target is 5.83 USD. This implies a price increase of 6.56% is expected in the next year compared to the current price of 5.47.
Can you provide the upcoming earnings date for MEDICAL PROPERTIES TRUST INC?
MEDICAL PROPERTIES TRUST INC (MPT) will report earnings on 2026-04-29.
Can you provide the consensus estimates for MEDICAL PROPERTIES TRUST INC next earnings?
The consensus EPS estimate for the next earnings of MEDICAL PROPERTIES TRUST INC (MPT) is 0 USD and the consensus revenue estimate is 245.52M USD.
How do analysts rate MEDICAL PROPERTIES TRUST INC (MPT)?
The consensus rating for MEDICAL PROPERTIES TRUST INC (MPT) is 53.75 / 100 . This indicates that analysts generally have a neutral outlook on the stock.